JenniferMichelleScaliciMD
Obstetrics & Gynecology • Mobile, ALGynecologic Oncology
Associate Professor, Interdisciplinary Clinical Oncology Division of Gynecologic Oncology
Dr. Scalici is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 Spring Hill Ave
Mobile, AL 36604Phone+1 251-665-8000Fax+1 251-665-8010
Education & Training
University of Virginia Medical CenterFellowship, Gynecologic Oncology, 2009 - 2012
McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
University of Alabama School of MedicineClass of 2005
Certifications & Licensure
GA State Medical License 2024 - 2025
AL State Medical License 2012 - 2024
VA State Medical License 2009 - 2012
IL State Medical License 2008 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 114 citationsALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.Erhong Meng, Aparna Mitra, Kaushlendra Tripathi, Michael A. Finan, Jennifer Scalici
Plos One. 2014-09-12 - 48 citationsRAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistanceRanganatha R. Somasagara, Sebastian M. Spencer, Kaushlendra Tripathi, David W. Clark, Chinnadurai Mani
Oncogene. 2017-08-14 - 67 citationsMinority participation in Gynecologic Oncology Group (GOG) StudiesJennifer Scalici, Michael A. Finan, Jennifer Black, Mary Danner Harmon, William Nicolson
Gynecologic Oncology. 2014-06-01
Press Mentions
Ovarian Cancer, a Very Rare Disease Often IgnoredSeptember 26th, 2019
Grant Support
- Novel NSAID derivatives for the Chemoprevention of Ovarian Cancer in the spontaneous hen modelDOD OCRP2017–2019
Professional Memberships
- Member
- Fellow
- Society of Gynecologic OncologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
